The partner ConsulTech GmbH will be responsible for the project management and will be active in dissemination and exploitation activities. The company will closely collaborate with the project coordinator Pieris and supports the different partners in administrative questions. ConsulTech will also create a web site, which will be a tool for com- munication within the consortium and with the scientific and business community.
Since 1992, ConsulTech GmbH (www.consultech-ct.de) supports small, medium sized and large companies as well as research institutes and universities in the acquisition of funding for their re- search and development projects. The company is a SME and has specialized on biotechnology, pharma and medical technology projects. ConsulTech supports its clients in applying for public funding from federal and state governments and the European Union. In addition, it supports pro- ject coordinators in project management and execution of R&D projects. ConsulTech identifies partners and suitable funding opportunities and manages consortia. Furthermore, ConsulTech has a long-lasting experience in formation of university spin-off companies and identifying market op- portunities. ConsulTech combines expertise from big pharma and from biotech start-up companies with experience in consulting of R&D and financing strategies in the Life Sciences sector.
The first EU funded project (Contrast agents for diagnostic imaging), which was initiated and managed by ConsulTech started within the 4th Framework of EU in 1994. Further projects initiated by ConsulTech followed. As the most recent project, ConsulTech is project manager of the MIRACLE consortium since 2010; within this research project new diagnostic tools in oncology are being developed. Another very interesting project is related to combating honeybee diseases and named SmartBees.
Project management - ConsulTech develops R&D strategies for small, medium-sized and large companies. Since many years, the company monitors and directs R&D projects in the LifeSciences and medical technology field through organizational and management activities that include reporting procedures and project financing and controlling. Furthermore, ConsulTech develops and implement business- and financing concepts and strategies for SMEs and spin-offs. The company has been initiating and managed EU funded projects since 1994 and has coordinated national and international research consortia.
Dissemination and exploitation - ConsulTech has long experience in market research of niche products in the LifeScience and medical technology sector and have successfully developed exploitation strategies for a number of clients a part of which is the generation and maintenance of internet web presences.
For more information, please contact
Daniel Schubart, PhD
ConsulTech GmbH
Morgensternstr. 24
D-12207 Berlin
Tel: +49-(0)30-7720 5920
email: schubart "at" consultech.de
Since 1992, ConsulTech GmbH (www.consultech-ct.de) supports small, medium sized and large companies as well as research institutes and universities in the acquisition of funding for their re- search and development projects. The company is a SME and has specialized on biotechnology, pharma and medical technology projects. ConsulTech supports its clients in applying for public funding from federal and state governments and the European Union. In addition, it supports pro- ject coordinators in project management and execution of R&D projects. ConsulTech identifies partners and suitable funding opportunities and manages consortia. Furthermore, ConsulTech has a long-lasting experience in formation of university spin-off companies and identifying market op- portunities. ConsulTech combines expertise from big pharma and from biotech start-up companies with experience in consulting of R&D and financing strategies in the Life Sciences sector.
The first EU funded project (Contrast agents for diagnostic imaging), which was initiated and managed by ConsulTech started within the 4th Framework of EU in 1994. Further projects initiated by ConsulTech followed. As the most recent project, ConsulTech is project manager of the MIRACLE consortium since 2010; within this research project new diagnostic tools in oncology are being developed. Another very interesting project is related to combating honeybee diseases and named SmartBees.
Project management - ConsulTech develops R&D strategies for small, medium-sized and large companies. Since many years, the company monitors and directs R&D projects in the LifeSciences and medical technology field through organizational and management activities that include reporting procedures and project financing and controlling. Furthermore, ConsulTech develops and implement business- and financing concepts and strategies for SMEs and spin-offs. The company has been initiating and managed EU funded projects since 1994 and has coordinated national and international research consortia.
Dissemination and exploitation - ConsulTech has long experience in market research of niche products in the LifeScience and medical technology sector and have successfully developed exploitation strategies for a number of clients a part of which is the generation and maintenance of internet web presences.
For more information, please contact
Daniel Schubart, PhD
ConsulTech GmbH
Morgensternstr. 24
D-12207 Berlin
Tel: +49-(0)30-7720 5920
email: schubart "at" consultech.de
ConsulTech Technologieberatung GmbH
